BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello, and welcome to the BioCryst Second Quarter twenty twenty six Earnings Call. At this time, all participants are in a listen only mode. After the speaker presentation, there will be a question and answer session. You will need to press 11 on your telephone. You will then hear an automated message advising your hand has been raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. It is now my pleasure to introduce Nick Wilder. Good morning, and welcome to BioCryst's second quarter twenty twenty six corporate update and financial results conference call. Participating with me today are President and CEO, Charlie Guyer Chief R and D Officer, Doctor. Sandeep Menon and Chief Financial Officer, Babur Ghias. A press release and slide presentation about today's news are available on our Investor Relations website. Today's call contains forward looking statements, including statements regarding future results, unaudited and forward looking financial information, as well as the company's future performance and or achievements. These statements are subject to known and unknown risks and uncertainties, which may cause our actual results, performance, or achievements to be materially different from any future results or performance expressed or implied in this presentation. For additional information, including a detailed discussion of these risks, please refer to slide two of the presentation. In addition, today's conference call includes non GAAP financial measures. For a reconciliation of these measures against the most directly comparable GAAP financial measure, please refer to the earnings press release available on our Investor Relations website. I'll now turn the call over to Charlie. Thanks, Nick. During ...